About
Maarten Dewilde is an Assistant Professor at the Faculty of Pharmaceutical Sciences, KU Leuven, affiliated with the Department of Pharmaceutical and Pharmacological Sciences. He leads the Therapeutic and Diagnostic Antibodies unit and is a member of the KU Leuven Antibody Centre (PharmAbs), Brain Institute (LBI), and Cancer Institute (LKI). His research focuses on antibody engineering, blood-brain barrier crossing, and neurodegenerative disease therapies.
- Research: Therapeutic nanobodies, Alzheimer's disease, gene therapy (AAV vectors), brain-targeted drug delivery
- Teaching: Pharmaceutical Biotechnology, BioPharmaceutical Research
His work involves collaborations across immunology, neuroscience, and pharmacology, with projects targeting complement inhibition, amyloid-beta pathology, and innovative biopharmaceutical delivery systems.
Dewilde's research has produced key publications on nanobody-mediated therapies in journals like Fluids and Barriers of the CNS and EMBO Molecular Medicine, focusing on neurodegenerative diseases and oncology.